Karina P. Sacardo
Av. Das Nações Unidas, Number 7815
Sao Paulo, SP 05425070, Brazil
Sao Paulo, SP 05425070, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world treatment outcomes in HR+ HER2- metastatic breast cancer patients treated with CDK4/6 inhibitors: Results from a reference center in Brazil.
Journal: Cancer treatment and research communications
Published: December 06, 2022
Knowledge, Practice, and Attitudes of Physicians in Low- and Middle-Income Countries on Fertility and Pregnancy-Related Issues in Young Women With Breast Cancer.
Journal: JCO global oncology
Published: January 13, 2022
Unique SLC12A2-ROS1 fusion is associated with marked response to crizotinib in lung adenocarcinoma.
Journal: SAGE open medical case reports
Published: December 15, 2021
Genomic and biological study of fusion genes as resistance mechanisms to EGFR inhibitors.
Journal: Nature communications
Published: July 30, 2021
Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma patient.
Journal: NPJ precision oncology
Published: August 04, 2020
Successful Drug Rechallenge Following Severe Acute Alectinib-induced Interstitial Lung Disease in a Patient With Advanced ALK-rearranged Lung Adenocarcinoma.
Journal: Clinical lung cancer
Published: May 12, 2020
Alectinib activity in chemotherapy-refractory metastatic RET-rearranged non-small cell lung carcinomas: A case series.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 10, 2019
Bevacizumab-associated osteonecrosis of the femur and tibia.
Journal: Oxford medical case reports
Published: March 08, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026